Programme

09:00 – 09:15

Welcome address

09:15 – 10:00

Keynote

Florence Dalenc

IUCT-Oncopole (Toulouse, France)

10:00 – 10:20

Oceane Dainese Marque

Sphingosine 1-phosphate triggers a keratinocyte-driven pro-inflammatory microenvironment that fuels phenotype switching in melanoma

10:20 – 10:40

Tech talk

InvivoGen

10:40 – 11:00

Coffee break

Industry sponsors stands

11:00 – 11:20

Imene Gasmi

Tuft cells remodel the mucosal immune microenvironment to promote intestinal tumourigenesis

11:20 – 11:40

Ludmila Recoules

ZBTB16 reduces CAF activation and limits stromal-mediated chemoresistance in pancreatic cancer

11:40 – 12:30

Interactive workshop

Dafna Gold Melchior

Who's in the Room? The Art & Science of Audience-Centered Communication

12:30 – 12:40

Tech talk

MedChemExpress

12:40 – 14:10

Lunch

Industry sponsors stands

In parallel Round table discussion · Meet the editor

14:10 – 14:55

Keynote

Sebastiaan van Heesch

Princess Maxima Center for Pediatric Oncology (Utrecht, The Netherlands)

14:55 – 15:15

Bartolomeo Bosco

MYCN ecDNA shapes immune landscape and immunotherapy resistance in high-risk neuroblastoma

15:15 – 15:35

Klara Ueberschar

Evolution of therapy resistance in neuroblastoma using patient-derived organoid models

15:35 – 15:45

Extended lightning talk

Jigna Kundnani

Exploring metabolic rewiring and cellular heterogeneity upon mutant IDH inhibition in low-grade glioma

15:45 – 15:55

Extended lightning talk

Lena Westerhoff

Neuroblastoma shows many alternative splicing events that point to oncogenic mechanisms and vulnerabilities

15:55 – 16:15

Coffee break

Industry sponsors stands

16:15 – 17:00

Patient advocate

Leona Knox

Head of Research at Solving Kids' Cancer UK

17:00 – 17:20

Lightning talks

1 minute per talk, selected on abstracts

17:20 – 18:45

Poster Session 1

18:45

Surprise!

20:00

Scientific Networking Evening

Icebreaker

09:00 – 09:45

Keynote

Matteo Iannacone

San Raffaele Scientific Institute (Milan, Italy)

09:45 – 10:05

Julia Majewska

Senescent macrophages drive immunosuppression: implications for cancer immunotherapy

10:05 – 10:15

Tech talk

Mantalys

10:15 – 10:25

Tech talk

Gen2i

10:25 – 10:45

Coffee break

Industry sponsors stands

10:45 – 11:30

Keynote

Marta Kovatcheva

IFOM — FIRC Institute of Molecular Oncology (Milan, Italy)

11:30 – 11:50

Lou Galliot

A germline PERK gain-of-function mutation rewires proteostasis, innate immunity and metabolism to recapitulate cancer stress adaptation

11:50 – 12:10

Jordi Badia-Ramentol

Functional diversity of cancer-associated fibroblasts shapes clinical outcomes in colorectal cancer

12:10 – 12:30

Lightning talks

1 minute per talk, selected on abstracts

12:30 – 14:25

Lunch

Industry sponsors stands

In parallel Meet the editor · Poster Session 2 (13:00 – 14:25)

14:25 – 15:10

Keynote

Altuna Akalin

Berlin Institute for Medical Systems Biology, Max Delbrück Center (Berlin, Germany)

How AI is reshaping life sciences research: from omics to healthcare

15:10 – 15:30

Mariano Molina

Integrative multiomic analysis identifies the tumor-adjacent liver microenvironment as a robust predictor of hepatocellular carcinoma recurrence

15:30 – 15:50

Sameer Panda

Tumor Immune MicroEnvironment (TIME) dictating lung cancer therapy resistance

15:50 – 16:10

Coffee break

Industry sponsors stands

16:10 – 16:50

Keynote

Daniela Marin

Senior Editor, The Lancet Haematology

“So you want to get published”

16:50

Closing remarks · Awards ceremony

Best poster & oral presentation awards